Key facts
- It has raised $13.7M; the latest was Early Stage VC ($13.7M) in Apr 2025.
- Notable investors include Xiamen Hi-Tech Innovation Center, Xiamen Science and Technology Industrial Group, Zhangzhou Pien Tze Huang Investment Management, Zhangzhou State-owned Capital Operation Group, DYEE Capital — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for jMedtech
- ·The full record, as it builds
Funding rounds
No funding rounds for jMedtech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About jMedtech
Developer and provider of medical coating solutions intended to provide medical device manufacturers with one-stop medical coating solutions. The company's solutions feature coating product customization, ready-to-use coating reagents, coating equipment and friction test equipment, product registration services, coating application training, coating OEM/ODM services, and technical services, enabling medical institutions across the world to leverage high-quality, medical-grade coating products in their medical devices.
- Sector
- Healthcare
- HQ
- Xiamen, China
- Founded
- 2013
- Website
- jmedtech.cn/
- Ownership
- Privately Held (backing)
jMedtech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in jMedtech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on jMedtech in its N-PORT filings yet. We sweep new filings monthly.